Literature DB >> 30138927

Oxidative Stress is the Principal Contributor to Inflammasome Activation in Retinal Pigment Epithelium Cells with Defunct Proteasomes and Autophagy.

Niina Piippo1, Eveliina Korhonen1, Maria Hytti1, Kati Kinnunen2,3, Kai Kaarniranta2,3, Anu Kauppinen1.   

Abstract

BACKGROUND/AIMS: Previously, we demonstrated that blockade of the intracellular clearance systems in human retinal pigment epithelial (RPE) cells by MG-132 and bafilomycin A1 (BafA) induces NLRP3 inflammasome signaling. Here, we have explored the activation mechanisms behind this process. NLRP3 is an intracellular receptor detecting factors ranging from the endogenous alarmins and adenosine triphosphate (ATP) to ultraviolet radiation and solid particles. Due to the plethora of triggers, the activation of NLRP3 is often indirect and can be mediated through several alternative pathways. Potassium efflux, lysosomal rupture, and oxidative stress are currently the main mechanisms associated with many activators.
METHODS: NLRP3 inflammasomes were activated in human RPE cells by blocking proteasomes and autophagy using MG-132 and bafilomycin A1 (BafA), respectively. P2X7 inhibitor A740003, potassium chloride (KCl), and glyburide, or N-acetyl-L-cysteine (NAC), ammonium pyrrolidinedithiocarbamate (APDC), diphenyleneiodonium chloride (DPI), and mito-TEMPO were added to cell cultures in order to study the role of potassium efflux and oxidative stress, respectively. IL-1β was measured using the ELISA method. ATP levels and cathepsin B activity were examined using commercial kits, and ROS levels using the fluorescent dye 2´,7´-dichlorodihydrofluorescein diacetate (DCFDA).
RESULTS: Elevated extracellular potassium prevented the priming factor IL-1α from inducing the production of reactive oxygen species (ROS). It also prevented IL-1β release after exposure of primed cells to MG-132 and BafA. Inflammasome activation increased extracellular ATP levels, which did not appear to trigger significant potassium efflux. The activity of the lysosomal enzyme, cathepsin B, was reduced by MG-132 and BafA, suggesting that cathepsin B was not playing any role in this phenomenon. Instead, MG-132 triggered ROS production already 30 min after exposure, but treatment with antioxidants blocking NADPH oxidase and mitochondria-derived ROS significantly prevented IL-1β release after this activating signal.
CONCLUSION: Our data suggest that oxidative stress strongly contributes to the NLRP3 inflammasome activation upon dysfunctional cellular clearance. Clarification of inflammasome activation mechanisms provides novel options for alleviating pathological inflammation present in aggregation diseases, such as age-related macular disease (AMD) and Alzheimer's disease.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Activation mechanism; Cathepsin B; Nlrp3 inflammasome; Potassium efflux; ROS

Mesh:

Substances:

Year:  2018        PMID: 30138927     DOI: 10.1159/000492886

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  17 in total

1.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

2.  Hypoxic expression of NLRP3 and VEGF in cultured retinal pigment epithelial cells: contribution of P2Y2 receptor signaling.

Authors:  Fabian Doktor; Philipp Prager; Peter Wiedemann; Leon Kohen; Andreas Bringmann; Margrit Hollborn
Journal:  Purinergic Signal       Date:  2018-11-10       Impact factor: 3.765

Review 3.  Oxidative and Nitrosative Stress in Age-Related Macular Degeneration: A Review of Their Role in Different Stages of Disease.

Authors:  Caterina Toma; Stefano De Cillà; Aurelio Palumbo; Divya Praveen Garhwal; Elena Grossini
Journal:  Antioxidants (Basel)       Date:  2021-04-23

Review 4.  Functional imaging of mitochondria in retinal diseases using flavoprotein fluorescence.

Authors:  Andrew X Chen; Thais F Conti; Grant L Hom; Tyler E Greenlee; Raffaele Raimondi; Isaac N Briskin; Collin A Rich; Reecha Kampani; Robert Engel; Sumit Sharma; Katherine E Talcott; Rishi P Singh
Journal:  Eye (Lond)       Date:  2020-07-24       Impact factor: 3.775

5.  Glycyrrhizin Protects the Diabetic Retina against Permeability, Neuronal, and Vascular Damage through Anti-Inflammatory Mechanisms.

Authors:  Li Liu; Youde Jiang; Jena J Steinle
Journal:  J Clin Med       Date:  2019-07-02       Impact factor: 4.241

Review 6.  The Diverse Roles of TIMP-3: Insights into Degenerative Diseases of the Senescent Retina and Brain.

Authors:  Jennifer M Dewing; Roxana O Carare; Andrew J Lotery; J Arjuna Ratnayaka
Journal:  Cells       Date:  2019-12-21       Impact factor: 6.600

7.  Differential Expression of Inflammasome-Related Genes in Induced Pluripotent Stem-Cell-Derived Retinal Pigment Epithelial Cells with or without History of Age-Related Macular Degeneration.

Authors:  Maria Hytti; Eveliina Korhonen; Heidi Hongisto; Kai Kaarniranta; Heli Skottman; Anu Kauppinen
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

8.  Characterization of the transcriptional response of Candida parapsilosis to the antifungal peptide MAF-1A.

Authors:  Rong Cheng; Wei Li; Klarke M Sample; Qiang Xu; Lin Liu; Fuxun Yu; Yingjie Nie; Xiangyan Zhang; Zhenhua Luo
Journal:  PeerJ       Date:  2020-09-07       Impact factor: 2.984

9.  Resvega Alleviates Hydroquinone-Induced Oxidative Stress in ARPE-19 Cells.

Authors:  Niina Bhattarai; Eveliina Korhonen; Maija Toppila; Ali Koskela; Kai Kaarniranta; Yashavanthi Mysore; Anu Kauppinen
Journal:  Int J Mol Sci       Date:  2020-03-17       Impact factor: 5.923

Review 10.  Potential Role of Myeloid-Derived Suppressor Cells (MDSCs) in Age-Related Macular Degeneration (AMD).

Authors:  Anu Kauppinen; Kai Kaarniranta; Antero Salminen
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.